haloperidol and senktide

haloperidol has been researched along with senktide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, PJ; Hagan, RM; Mason, GS; Stephens-Smith, M1
Dourish, CT; Iversen, SD; Stoessl, AJ1
Alberch, J; Arenas, E; Marsal, J; Pérez-Navarro, E1
Cenarruzabeitia, E; Del Rio, J; Lasheras, B; Ramírez, MJ1
Cluderay, JE; Dada, A; Davies, CH; Dawson, LA; de la Flor, R; Hagan, JJ; Hill, MD; Jones, DN; Jones, GA; Langmead, CJ; Murkitt, GS; Smith, PW; Southam, E; Watson, JM; Wu, Z1
Couture, R; De Brito Gariepy, H1

Other Studies

6 other study(ies) available for haloperidol and senktide

ArticleYear
Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Neuropeptides, 1991, Volume: 19, Issue:2

    Topics: Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Dopamine; Haloperidol; Limbic System; Male; Mesencephalon; Molecular Sequence Data; Motor Activity; Neural Pathways; Neurokinin A; Peptide Fragments; Rats; Receptors, Neurotransmitter; Receptors, Tachykinin; Substance P; Substantia Nigra; Tegmentum Mesencephali

1991
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
    Psychopharmacology, 1988, Volume: 95, Issue:4

    Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Haloperidol; Hydroxydopamines; Injections, Subcutaneous; Male; Oxidopamine; Parasympathetic Nervous System; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Scopolamine; Stereotyped Behavior; Substance P; Yawning

1988
Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons.
    Naunyn-Schmiedeberg's archives of pharmacology, 1993, Volume: 348, Issue:5

    Topics: Acetylcholine; Animals; Benzazepines; Clozapine; Dopamine; Dopamine Agents; Haloperidol; In Vitro Techniques; Male; Neostriatum; Neurons; Oxidopamine; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Substance P; Tachykinins

1993
5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Brain research, 1997, May-16, Volume: 757, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Ergolines; Haloperidol; In Vitro Techniques; Ketanserin; Male; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Physalaemin; Potassium; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Substance P

1997
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics.
    European journal of pharmacology, 2010, Feb-10, Volume: 627, Issue:1-3

    Topics: Aminoquinolines; Animals; Behavior, Animal; Brain; Cerebral Cortex; Cloning, Molecular; Dopamine; Extracellular Space; Guinea Pigs; Habenula; Haloperidol; Humans; Inositol Phosphates; Male; Microdialysis; Neurokinin B; Neurons; Nucleus Accumbens; Peptide Fragments; Peptides; Quinolines; Rats; Receptors, Tachykinin; Substance P

2010
Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
    British journal of pharmacology, 2010, Volume: 161, Issue:8

    Topics: Animals; Benzazepines; Blood Pressure; Dopamine; Haloperidol; Heart Rate; Hypertension; Ibotenic Acid; Indoles; Male; Oligopeptides; Peptide Fragments; Quinolines; Raclopride; Rats; Rats, Inbred SHR; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area

2010